Related Experiment Video

Updated: Sep 20, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide

Francois Vandenesch1, Timothy Naimi, Mark C Enright

  • 1INSERM E0230, Lyon, France.

Emerging Infectious Diseases
|September 12, 2003
PubMed

Insights

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) strains share common genetic markers like the Panton-Valentine leukocidin locus. However, distinct genetic backgrounds and toxin gene distributions vary by geographic origin.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are a growing global concern.
  • Understanding the genetic relatedness of CA-MRSA strains is crucial for tracking outbreaks and developing effective interventions.

Purpose of the Study:

  • To identify common genetic markers among CA-MRSA isolates from diverse geographic locations.
  • To analyze the genetic background and virulence factors of CA-MRSA strains across different continents.

Main Methods:

  • Polymerase chain reaction (PCR) was used to detect 24 virulence factors and the methicillin-resistance determinant.
  • Pulsed-field gel electrophoresis (PFGE) and multi-locus sequence typing (MLST) were employed for genetic background analysis.

Main Results:

  • CA-MRSA strains universally possessed a type IV SCCmec cassette and the Panton-Valentine leukocidin (PVL) locus.
  • Other toxin gene distributions were continent-specific.
  • PFGE and MLST revealed distinct genetic backgrounds for CA-MRSA based on geographic origin, primarily within the agr3 background, differing from hospital-acquired MRSA.

Conclusions:

  • CA-MRSA strains exhibit conserved genetic elements (SCCmec type IV, PVL locus) but also significant geographic genetic diversity.
  • The genetic profiles of CA-MRSA strains are distinct from hospital-acquired MRSA strains within the same continental regions.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...